These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9795767)
1. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894 [TBL] [Abstract][Full Text] [Related]
3. Epitope spreading: a mechanism for progression of autoimmune disease. Tuohy VK; Kinkel RP Arch Immunol Ther Exp (Warsz); 2000; 48(5):347-51. PubMed ID: 11140461 [TBL] [Abstract][Full Text] [Related]
4. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M; Johnson JM; Tuohy VK J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934 [TBL] [Abstract][Full Text] [Related]
5. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163 [TBL] [Abstract][Full Text] [Related]
6. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M; Johnson JM; Tuohy VK J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907 [TBL] [Abstract][Full Text] [Related]
7. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. Jones RE; Bourdette D; Moes N; Vandenbark A; Zamora A; Offner H J Immunol; 2003 Feb; 170(4):1690-8. PubMed ID: 12574332 [TBL] [Abstract][Full Text] [Related]
8. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764 [TBL] [Abstract][Full Text] [Related]
9. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821 [TBL] [Abstract][Full Text] [Related]
12. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658 [TBL] [Abstract][Full Text] [Related]
13. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Yu M; Kinkel RP; Weinstock-Guttman B; Cook DJ; Tuohy VK Hum Immunol; 1998 Jan; 59(1):15-24. PubMed ID: 9544235 [TBL] [Abstract][Full Text] [Related]
14. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718 [TBL] [Abstract][Full Text] [Related]
15. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. de Rosbo NK; Kaye JF; Eisenstein M; Mendel I; Hoeftberger R; Lassmann H; Milo R; Ben-Nun A J Immunol; 2004 Jul; 173(2):1426-35. PubMed ID: 15240739 [TBL] [Abstract][Full Text] [Related]
16. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Miller SD; McRae BL; Vanderlugt CL; Nikcevich KM; Pope JG; Pope L; Karpus WJ Immunol Rev; 1995 Apr; 144():225-44. PubMed ID: 7590815 [TBL] [Abstract][Full Text] [Related]
17. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Miller SD; McMahon EJ; Schreiner B; Bailey SL Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826 [TBL] [Abstract][Full Text] [Related]
18. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis. Tian J; Song M; Kaufman DL Sci Rep; 2021 Mar; 11(1):5402. PubMed ID: 33686135 [TBL] [Abstract][Full Text] [Related]
19. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Miller SD; Eagar TN Adv Exp Med Biol; 2001; 490():99-107. PubMed ID: 11505979 [TBL] [Abstract][Full Text] [Related]
20. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]